Read more: Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol
Read more: Novartis receives positive CHMP opinion for Leqvio®* (inclisiran), a potential first-in-class siRNA for the treatment of high cholesterol
Follow this link: Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock
See the rest here: Theratechnologies Appoints Two New Board Members
Read the original post: Aimmune Receives Positive CHMP Opinion on PALFORZIA® for the Treatment of Patients with Peanut Allergy in Europe
Go here to see the original: Spero Therapeutics to Present Data for All Pipeline Programs at IDWeek 2020
Read the rest here: Zogenix Receives Positive CHMP Opinion for FINTEPLA® (Fenfluramine) Oral Solution for the Treatment of Seizures in Patients with Dravet Syndrome
Read this article: Beyond Air® Presents Positive New Preclinical Data for the Use of a Single Injection of Gaseous Nitric Oxide as a Novel In situ Cancer Vaccination
Originally posted here: CHMP recommends approval of Dupixent® (dupilumab) for children aged 6 to 11 years with severe atopic dermatitis
More: SPACs Show Investors Faster, Simpler Way to Go Public
Read more: Psychedelics Experiencing Renaissance, Offer Tremendous Treatment Potential
Recent Comments